Clinical Trial Update: Nuvigil or Placebo in Newly Diagnosed Malignant Glioma [Phase 2]

View source ↗

Summary

A Phase 2 randomized trial of Nuvigil (armodafinil) versus placebo in newly diagnosed malignant glioma was terminated. Results were posted in 2013.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Malignant Glioma

Drugs mentioned

• NUVIGIL (armodafinil)

Snippet

Sponsor: H. Lee Moffitt Cancer Center and Research Institute | Conditions: Malignant Glioma | Phase 2 | Status: TERMINATED | Results posted: 2013-12-16